Sherwin-Williams (NYSE:SHW) PT Raised to $450.00 at Morgan Stanley

Sherwin-Williams (NYSE:SHWFree Report) had its price objective lifted by Morgan Stanley from $375.00 to $450.00 in a report released on Friday morning, Benzinga reports. They currently have an overweight rating on the specialty chemicals company’s stock.

SHW has been the subject of several other reports. Barclays boosted their price objective on shares of Sherwin-Williams from $315.00 to $355.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. BMO Capital Markets upped their price target on Sherwin-Williams from $400.00 to $425.00 and gave the stock an “outperform” rating in a research note on Monday, September 30th. The Goldman Sachs Group lifted their price objective on Sherwin-Williams from $344.00 to $390.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Evercore ISI increased their target price on shares of Sherwin-Williams from $365.00 to $380.00 and gave the stock an “outperform” rating in a research report on Friday, August 30th. Finally, Wells Fargo & Company lifted their price target on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 15th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Sherwin-Williams has an average rating of “Moderate Buy” and a consensus price target of $383.35.

View Our Latest Research Report on Sherwin-Williams

Sherwin-Williams Stock Performance

NYSE SHW opened at $381.75 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 2.17. The company has a market capitalization of $96.30 billion, a PE ratio of 38.91, a price-to-earnings-growth ratio of 3.04 and a beta of 1.17. The business’s 50-day moving average price is $371.35 and its 200 day moving average price is $334.24. Sherwin-Williams has a twelve month low of $232.06 and a twelve month high of $392.57.

Sherwin-Williams (NYSE:SHWGet Free Report) last released its earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.51 by $0.19. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. The business had revenue of $6.27 billion for the quarter, compared to analysts’ expectations of $6.33 billion. During the same period last year, the company earned $3.29 earnings per share. The company’s quarterly revenue was up .5% on a year-over-year basis. On average, research analysts predict that Sherwin-Williams will post 11.49 earnings per share for the current year.

Sherwin-Williams Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be paid a $0.715 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $2.86 dividend on an annualized basis and a dividend yield of 0.75%. Sherwin-Williams’s dividend payout ratio (DPR) is presently 29.15%.

Insider Activity

In related news, CFO Allen J. Mistysyn sold 14,520 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the transaction, the chief financial officer now directly owns 63,520 shares in the company, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Sherwin-Williams

A number of institutional investors have recently modified their holdings of the business. Surience Private Wealth LLC bought a new stake in shares of Sherwin-Williams in the 3rd quarter worth approximately $4,064,000. Northwest Investment Counselors LLC bought a new position in Sherwin-Williams in the 3rd quarter valued at about $52,000. Everence Capital Management Inc. bought a new position in shares of Sherwin-Williams in the third quarter valued at approximately $573,000. Toth Financial Advisory Corp increased its position in shares of Sherwin-Williams by 0.4% during the 3rd quarter. Toth Financial Advisory Corp now owns 29,095 shares of the specialty chemicals company’s stock valued at $11,105,000 after purchasing an additional 109 shares during the period. Finally, Suncoast Equity Management grew its holdings in Sherwin-Williams by 1.3% during the third quarter. Suncoast Equity Management now owns 12,826 shares of the specialty chemicals company’s stock worth $4,895,000 after acquiring an additional 170 shares during the period. Institutional investors own 77.67% of the company’s stock.

Sherwin-Williams Company Profile

(Get Free Report)

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.

Read More

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.